Factors associated with the duration of SARS-CoV-2 infection in healthcare professionals at a second-level public hospital in the Community of Madrid (Spain) during the sixth wave

e202302012

Authors

  • Marta de San Segundo Reyes Servicio de Prevención Mancomunado de Grupo, Hospital Universitario Infanta Leonor. Madrid. España.
  • Juan José Granizo Martínez Servicio de Medicina Preventiva, Hospital Universitario Infanta Cristina. Parla (Madrid). España.
  • María Carolina Veiga Crespo Servicio de Prevención Mancomunado de Grupo, Hospital Universitario Infanta Leonor. Madrid. España.
  • Antonio Sanchís Ruiz Servicio de Prevención Mancomunado de Grupo, Hospital Universitario Infanta Leonor. Madrid. España.
  • Irene Camacho Muñoz Servicio de Prevención Mancomunado de Grupo, Hospital Universitario Infanta Leonor. Madrid. España.
  • María Ángeles Sánchez-Uriz Servicio de Prevención Mancomunado de Grupo, Hospital Universitario Infanta Leonor. Madrid. España.

Keywords:

COVID-19, Vaccination, Infection, Make negative, Health workers, Occupational risk prevention

Abstract

BACKGROUND // The incidence of COVID-19 infections among health professionals during the sixth wave has suffered an exponential increase, mainly due to the rapid community transmission caused by the Omicron variant. The main objective of the study was to evaluate the time to negativization in COVID-positive health professionals during the sixth wave, according to the PDIA result; and secondarily, to evaluate the possible influence of other factors (previous infection, vaccination, sex, age, job position) on the time to get negative status.
METHODS // A descriptive, longitudinal, observational and retrospective study was carried out at Infanta Sofía University Hospital (Madrid, Spain). Made from the registry of the Occupational Risk Prevention Service of suspected or confirmed cases of SARS-COV-2 infection in health professionals, during the period between November 1, 2021 and February 28, 2022. Bivariate comparisons were made using Mann Whitney, Kruskal Wallis or Chi-square test (or exact test) according to variables. Subsequently, logistic regression (explanatory model) was performed.
RESULTS // The cumulative incidence of SARS-COV-2 infection in health professionals was 23.07%. The mean time to become negative was 9.94 days. Only the history of previous SARS-COV-2 infection had a statistically significant influence on the time to negativization of PDIA. The variables vaccination, sex and age had no effect on the time to negativization of PDIA.
CONCLUSIONS // Professionals with a history of COVID-19 infection present lower times of negativization than those who had not have the disease. The results of our study confirm the immune escape of the vaccine against COVID-19, since more than 95% of those infected had received a complete vaccination schedule.

Downloads

Download data is not yet available.

References

Número acumulado de casos confirmados y muertes del coronavirus en España [Internet]. Statista. 2022. Disponible en: https://es.statista.com/estadisticas/1107506/covid-19-casos-confirmados-muertes-y-recuperados-por-dia-espana/

Communication from the Commission to the European Parliament, the European Council, the Council and the European Investment Bank EU. Strategy for COVID-19 vaccines [Internet]. European Commission; 2020 jun p. 10. Disponible en: https://ec.europa.eu/info/sites/default/files/communication-eu-strategy-vaccines-covid19_en.pdf

Communication from the Commission to the European Parliament and the Council. Preparedness for COVID-19 vaccination strategies and vaccine deployment [Internet]. European Commission; 2020 [citado 8 de mayo de 2022]. p. 16. Disponible en: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM:2020:0680:FIN

Commission decision of 15.12.2020 on implementing Advance Purchase Agreements on COVID-19 vaccines [Internet]. European Commission; 2020 dic p. 3. Disponible en: https://ec.europa.eu/info/sites/default/files/commission-decision-implementing-advance-purchase-agreements-covid-19-vaccines.pdf

Empezamos mañana la vacunación frente al COVID-19 de los sanitarios de primera línea [Internet]. [citado 26 de marzo de 2022]. Disponible en: https://www.comunidad.madrid/noticias/2021/01/08/empezamos-manana-vacunacion-frente-covid-19-sanitarios-primera-linea

Salud Pública aprueba la tercera dosis covid a los profesionales sanitarios [Internet]. [citado 26 de marzo de 2022]. Disponible en: https://www.redaccionmedica.com/secciones/sanidad-hoy/salud-publica-aprueba-la-tercera-dosis-covid-a-los-profesionales-sanitarios-8891

Centro para el Control y la Prevención de Enfermedades de Estados Unidos. COVID-19. [Internet]. [citado 25 de abril de 2022]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Estrategia de detección precoz, vigilancia y control de COVID-19 [Internet]. Dirección General de Salud Pública. Consejeria de Sanidad. Comunidad de Madrid; 2021 [citado 25 de abril de 2022]. Disponible en: https://www.comunidad.madrid/servicios/salud/coronavirus

Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. 24 de febrero de 2022;602(7898):654-656.

Grabowski F, Kochańczyk M, Lipniacki T. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion. Viruses. 30 de enero de 2022;14(2):294.

Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY et al. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. Preprint [Internet]. 4 de enero de 2021 [citado 28 de abril de 2022]; Disponible en: http://biorxiv.org/lookup/doi/10.1101/2020.12.31.425021

Liu L, Iketani S, Guo Y, Chan JFW, Wang M, Liu L et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 24 de febrero de 2022;602(7898):676-681.

Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E et al. COVID-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 21 de abril de 2022;386(16):1532-1546.

Tartof SY, Slezak JM, Puzniak L, Hong V, Xie F, Ackerson BK et al. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control study. Lancet Respir Med. abril de 2022;S2213260022001011.

Pérez LMC, Rosario ENP, Russert PH, Pérez DG. Impacto de la variabilidad de criterios para el retorno al trabajo del personal sanitario con enfermedad COVID-19: Estudio multicéntrico en Navarra, La Rioja y Galicia. Marzo-septiembre de 2020. Rev Esp Salud Pública. 2021; 95: 25 de octubre e202110182.

Suarez-Garcıa I, Abascal PL. SARS-CoV-2 infection among healthcare workers in a hospital in Madrid, Spain. J Hosp Infect. 2020;8.

Pérez-García F, Pérez-Zapata A, Varela NA, Ramos ES, Barzano CC, García BC et al. Seroprevalencia frente a SARS-CoV-2 en los trabajadores de un hospital de Madrid. Rev Esp Salud Pública. 2021; 95: 22 de octubre e202110176.

Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Posicionamiento de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) ante la situación actual (7 de febrero 2022) de la pandemia de COVID-19 en España [Internet]. 2022. Disponible en: https://seimc.org/contenidos/noticias/2022/seimc-dc-2022-Posicionamiento_SEIMC_COVID19.pdf

Rhee C, Kanjilal S, Baker M, Klompas M. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? Clin Infect Dis. 26 de abril de 2021;72(8):1467-1474.

Published

2023-02-15

How to Cite

1.
de San Segundo Reyes M, Granizo Martínez JJ, Veiga Crespo MC, Sanchís Ruiz A, Camacho Muñoz I, Sánchez-Uriz M Ángeles. Factors associated with the duration of SARS-CoV-2 infection in healthcare professionals at a second-level public hospital in the Community of Madrid (Spain) during the sixth wave: e202302012. Rev Esp Salud Pública [Internet]. 2023 Feb. 15 [cited 2024 May 20];97:10 páginas. Available from: https://ojs.sanidad.gob.es/index.php/resp/article/view/92